Details of the Drug

General Information of Drug (ID: DMD36WS)

Drug Name

1,1,1,3-Tetrafluoro-heptadecan-2-one

Synonyms

CHEMBL462389

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

#Ro5 Violations (Lipinski): 2

Molecular Weight (mw)

326.4

Logarithm of the Partition Coefficient (xlogp)

8.7

Rotatable Bond Count (rotbonds)

14

Hydrogen Bond Donor Count (hbonddonor)

0

Hydrogen Bond Acceptor Count (hbondacc)

5

Chemical Identifiers

Formula: C17H30F4O
IUPAC Name: 1,1,1,3-tetrafluoroheptadecan-2-one
Canonical SMILES: CCCCCCCCCCCCCCC(C(=O)C(F)(F)F)F
InChI: InChI=1S/C17H30F4O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15(18)16(22)17(19,20)21/h15H,2-14H2,1H3
InChIKey: HCIDRHZIAMIVIL-UHFFFAOYSA-N

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Cytosolic phospholipase A2 (GIVA cPLA2)	TTT1JVS	PA24A_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Synthesis of polyfluoro ketones for selective inhibition of human phospholipase A2 enzymes. J Med Chem. 2008 Dec 25;51(24):8027-37.